Home › Non-Muscle Invasive Bladder Cancer › Ohio › Cincinnati
Non-Muscle Invasive Bladder Cancer clinical trials in Cincinnati, OH
3 studies for Non-Muscle Invasive Bladder Cancer are looking for participants at sites in and around Cincinnati (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
RecruitingPhase 2
- TriState Urologic Services PSC Inc. dba The Urology Group ( Site 0122), Cincinnati
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
RecruitingPhase 1
- University of Cincinnati Medical Center (UCMC), Cincinnati
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
RecruitingPhase 1/2
- University of Cincinnati Medical Center, Cincinnati
Non-Muscle Invasive Bladder Cancer trials in other cities
- New York City, NY10 studies
- Dallas, TX10 studies
- Columbus, OH10 studies
- Edison, NJ9 studies
- Myrtle Beach, SC9 studies
- Syracuse, NY8 studies
- Baltimore, MD8 studies
- Nashville, TN8 studies
- Indianapolis, IN7 studies
- Birmingham, AL7 studies
- Houston, TX7 studies
- Atlanta, GA7 studies
Other studies in Cincinnati
- Non-Small Cell Lung Cancer35 studies
- Cancer (all types)28 studies
- Breast Cancer25 studies
- Heart Failure24 studies
- Colorectal Cancer21 studies
- Obesity20 studies
- Metastatic Cancer20 studies
- Acute Myeloid Leukemia20 studies
- Lung Cancer19 studies
- Ovarian Cancer19 studies
- Prostate Cancer18 studies
- Melanoma17 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.